Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Krsnaa Diagnostics IPO is a book build issue of ₹1,213.33 crores. The issue is a combination of fresh issue of 0.42 crore shares aggregating to ₹400.84 crores and offer for sale of 0.85 crore shares aggregating to ₹812.49 crores.
Krsnaa Diagnostics IPO bidding started from Aug 4, 2021 and ended on Aug 6, 2021. The allotment for Krsnaa Diagnostics IPO was finalized on Aug 11, 2021. The shares got listed on BSE, NSE on Aug 16, 2021.
Krsnaa Diagnostics IPO price band is set at ₹954.00 per share . The lot size for an application is 15. The minimum amount of investment required by an retail is ₹13,995 (15 shares). The lot size investment for sNII is 14 lots (210 shares), amounting to ₹2,00,340, and for bNII, it is 70 lots (1,050 shares), amounting to ₹10,01,700.
The issue includes a reservation of up to 2,32,288 shares for employees offered at a discount of ₹93.00 to the issue price.
Dam Capital Advisors Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Krsnaa Diagnostics IPO RHP for detailed Information.
| IPO Date | August 4, 2021 to August 6, 2021 |
| Listing Date | August 16, 2021 |
| Face Value | ₹5 per share |
| Issue Price Band | ₹933 to ₹954 per share |
| Issue Price Final | ₹954 per share |
| Lot Size | 15 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 1,27,31,605 shares (aggregating up to ₹1,213.33 Cr) |
| Fresh Issue | 42,06,085 shares (aggregating up to ₹400.84 Cr) |
| Offer for Sale | 85,25,520 shares of ₹5 (aggregating up to ₹812.49 Cr) |
| Employee Discount | ₹93.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,71,91,528 shares |
| Share Holding Post Issue | 3,14,07,044 shares |
Krsnaa Diagnostics IPO offers total 1,27,41,036 shares. Out of which 93,81,562 (73.63%) allocated to QIB, 37,52,625 (29.45%) allocated to QIB, 18,76,312 (14.73%) allocated to NII, 12,50,874 (9.82%) allocated to RII and 56,28,937 (44.18%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 93,81,562 (73.63%) | NA |
| − Anchor Investor Shares Offered | 56,28,937 (44.18%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 37,52,625 (29.45%) | NA |
| NII (HNI) Shares Offered | 18,76,312 (14.73%) | NA |
| Retail Shares Offered | 12,50,874 (9.82%) | 83,391 |
| Employee Shares Offered | 2,32,288 (1.82%) | NA |
| Total Shares Offered | 1,27,41,036 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Krsnaa Diagnostics IPO opens on August 4, 2021, and closes on August 6, 2021.
| IPO Open Date | Wed, Aug 4, 2021 |
| IPO Close Date | Fri, Aug 6, 2021 |
| Tentative Allotment | Wed, Aug 11, 2021 |
| Initiation of Refunds | Thu, Aug 12, 2021 |
| Credit of Shares to Demat | Fri, Aug 13, 2021 |
| Tentative Listing Date | Mon, Aug 16, 2021 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Aug 6, 2021 |
Investors can bid for a minimum of 15 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹14,310 |
| Retail (Max) | 13 | 195 | ₹1,86,030 |
| S-HNI (Min) | 14 | 210 | ₹2,00,340 |
| S-HNI (Max) | 69 | 1,035 | ₹9,87,390 |
| B-HNI (Min) | 70 | 1,050 | ₹10,01,700 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.
The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients.
Competitive Strengths
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 6,045.30 | 6,299.82 | 5,289.85 | ||
| Total Revenue | 6,614.76 | 2,713.79 | 2,143.15 | ||
| Profit After Tax | 1,849.29 | (1,119.51) | (580.57) | ||
The Company Krsnaa Diagnostics IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Proposing to finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra. | 150.81 |
| 2 | Repayment/pre-payment, in full or part, of borrowings from banks and other lenders availed by the Company; and | 146.08 |
| 3 | General corporate purposes | 81.74 |
[Dilip Davda] Healthcare sector counters marked hefty gains amidst pandemic scare and currently witnessing some corrections from the higher levels. KDL has posted net profits for FY21 on account of one-time gains and even with these earnings, its issue is aggressively priced at a P/E of 80+ and is thus a costly bet against listed peers. In fact, it has a negative P/E. The segment is highly fragmented with many unorganized players and also having tough competitions from organized players. Considering all these, cash surplus/risk seekers may consider investing in this highly-priced offer, others can avoid. Read detail review...
| Listing Date | August 16, 2021 |
| BSE Script Code | 543328 |
| NSE Symbol | KRSNAA |
| ISIN | INE08LI01020 |
| Final Issue Price | ₹954 per share |
| BSE Listing Group | B |
Krsnaa Diagnostics Ltd.
S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1,
Chinchwad, Taluka – Haveli, Pune - 411 019
Pune, Maharashtra
Phone: +91 20 4695 4695
Email: cs@krsnadiagnostics.com
Website: https://krsnaadiagnostics.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: krsnaa.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Krsnaa Diagnostics IPO is a main-board IPO of 1,27,31,605 equity shares of the face value of ₹5 aggregating up to ₹1,213.33 Crores. The issue is priced at ₹954 per share. The minimum order quantity is 15.
The IPO opens on August 4, 2021, and closes on August 6, 2021.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Krsnaa Diagnostics IPO using UPI as a payment gateway. Zerodha customers can apply in Krsnaa Diagnostics IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Krsnaa Diagnostics IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Krsnaa Diagnostics IPO opens on August 4, 2021 and closes on August 6, 2021.
Krsnaa Diagnostics IPO lot size is 15, and the minimum amount required for application is ₹14,310.
You can apply in Krsnaa Diagnostics IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Krsnaa Diagnostics IPO will be done on Wednesday, August 11, 2021, and the allotted shares will be credited to your demat account by Friday, August 13, 2021. Check the Krsnaa Diagnostics IPO allotment status.
The Krsnaa Diagnostics IPO listing date is on Monday, August 16, 2021.
Useful Articles
RHP